Darjatmoko SR - Search Results

1

Effectiveness of 1alpha-hydroxyvitamin D2 in inhibiting tumor growth in a murine transgenic pigmented ocular tumor model.

Albert DM, Kumar A, Strugnell SA, Darjatmoko SR, Lokken JM, Lindstrom MJ, Damico CM, Patel S. Albert DM, et al. Among authors: darjatmoko sr. Arch Ophthalmol. 2004 Sep;122(9):1365-9. doi: 10.1001/archopht.122.9.1365. Arch Ophthalmol. 2004. PMID: 15364717

2

Antineoplastic effect of 1,25-dihydroxy-16-ene-23-yne-vitamin D3 analogue in transgenic mice with retinoblastoma.

Shternfeld IS, Lasudry JG, Chappell RJ, Darjatmoko SR, Albert DM. Shternfeld IS, et al. Among authors: darjatmoko sr. Arch Ophthalmol. 1996 Nov;114(11):1396-401. doi: 10.1001/archopht.1996.01100140596012. Arch Ophthalmol. 1996. PMID: 8906031

3

Treatment of spontaneously arising retinoblastoma tumors in transgenic mice with an attenuated herpes simplex virus mutant.

Brandt CR, Imesch PD, Robinson NL, Syed NA, Untawale S, Darjatmoko SR, Chappell RJ, Heinzelman P, Albert DM. Brandt CR, et al. Among authors: darjatmoko sr. Virology. 1997 Mar 3;229(1):283-91. doi: 10.1006/viro.1996.8414. Virology. 1997. PMID: 9123872 Free article.

4

Toxicity and dose-response studies of 1,25-(OH)2-16-ene-23-yne vitamin D3 in transgenic mice.

Wilkerson CL, Darjatmoko SR, Lindstrom MJ, Albert DM. Wilkerson CL, et al. Among authors: darjatmoko sr. Clin Cancer Res. 1998 Sep;4(9):2253-6. Clin Cancer Res. 1998. PMID: 9748146

5

Transgenic mice with pigmented intraocular tumors: tissue of origin and treatment.

Syed NA, Windle JJ, Darjatmoko SR, Lokken JM, Steeves RA, Chappell R, Wallow IH, Koop BA, Mangold G, Howes KA, Albert DM. Syed NA, et al. Among authors: darjatmoko sr. Invest Ophthalmol Vis Sci. 1998 Dec;39(13):2800-5. Invest Ophthalmol Vis Sci. 1998. PMID: 9856795

6

Antineoplastic effect and toxicity of 1,25-dihydroxy-16-ene-23-yne-vitamin D3 in athymic mice with Y-79 human retinoblastoma tumors.

Sabet SJ, Darjatmoko SR, Lindstrom MJ, Albert DM. Sabet SJ, et al. Among authors: darjatmoko sr. Arch Ophthalmol. 1999 Mar;117(3):365-70. doi: 10.1001/archopht.117.3.365. Arch Ophthalmol. 1999. PMID: 10088815

7

Toxicity and dose-response studies of 1alpha-hydroxyvitamin D2 in a retinoblastoma xenograft model.

Grostern RJ, Bryar PJ, Zimbric ML, Darjatmoko SR, Lissauer BJ, Lindstrom MJ, Lokken JM, Strugnell SA, Albert DM. Grostern RJ, et al. Among authors: darjatmoko sr. Arch Ophthalmol. 2002 May;120(5):607-12. doi: 10.1001/archopht.120.5.607. Arch Ophthalmol. 2002. PMID: 12003610

8

Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma.

Audo I, Darjatmoko SR, Schlamp CL, Lokken JM, Lindstrom MJ, Albert DM, Nickells RW. Audo I, et al. Among authors: darjatmoko sr. Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4192-9. doi: 10.1167/iovs.02-1198. Invest Ophthalmol Vis Sci. 2003. PMID: 14507860

9

Effectiveness of vitamin D analogues in treating large tumors and during prolonged use in murine retinoblastoma models.

Albert DM, Kumar A, Strugnell SA, Darjatmoko SR, Lokken JM, Lindstrom MJ, Patel S. Albert DM, et al. Among authors: darjatmoko sr. Arch Ophthalmol. 2004 Sep;122(9):1357-62. doi: 10.1001/archopht.122.9.1357. Arch Ophthalmol. 2004. PMID: 15364716

10

Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells.

Sareen D, van Ginkel PR, Takach JC, Mohiuddin A, Darjatmoko SR, Albert DM, Polans AS. Sareen D, et al. Among authors: darjatmoko sr. Invest Ophthalmol Vis Sci. 2006 Sep;47(9):3708-16. doi: 10.1167/iovs.06-0119. Invest Ophthalmol Vis Sci. 2006. PMID: 16936077

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters